Draft guideline on the evaluation of medicinal products for the treatment of irritable bowel syndrome - Revision 1

  • Email
  • Help

Document details

Download document Draft guideline on the evaluation of medicinal products for the treatment of irritable bowel syndrome - Revision 1
Reference number CPMP/EWP/785/97 Rev. 1
Status draft: consultation closed
First published 19/07/2013
Last updated 19/07/2013

Summary

This guideline intends to address the European Union regulatory position in the main topics of clinical development of new medicinal products in the treatment of patients with irritable bowel syndrome.